Showing results (1-10 of 127) with videos related to
Sort By:
Pageof 13
Seminars in Thrombosis and Hemostasis|November 8, 2014
Glycosaminoglycans: anticoagulant and nonanticoagulant actions: a short history of symposia held at villa vigoniJob Harenberg, Benito Casu, Roland Krämer, et al.Seminars in Thrombosis and Hemostasis|September 24, 2002
Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivativeJob Harenberg, Benito Casu, Marco Guerrini, et al.Thrombosis Research|April 13, 2016
Laboratory determination of old and new targeted anticoagulant agents for prevention of bleeding and thrombotic events in cancer patientsJob HarenbergMedizinische Klinik (Munich, Germany : 1983)|October 11, 2003
[Treatment of thrombosis with low-molecular-weight heparin. Comparison of body weight-adjusted and fixed dosage]Job HarenbergCurrent Opinion in Pulmonary Medicine|August 13, 2002
Fixed-dose versus adjusted-dose low molecular weight heparin for the initial treatment of patients with deep venous thrombosisJob HarenbergClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 17, 2011
Differences of present recommendations and guidelines for generic low-molecular-weight heparins: is there room for harmonizationJob HarenbergThrombosis Research|January 26, 2011
Overview on guidelines and recommendations for generic low-molecular-weight heparinsJob HarenbergExpert Review of Clinical Pharmacology|November 25, 2011
Idraparinux and idrabiotaparinuxJob HarenbergSeminars in Thrombosis and Hemostasis|February 14, 2009
Development of new anticoagulants: present and futureJob HarenbergSeminars in Thrombosis and Hemostasis|September 30, 2009
New anticoagulants in atrial fibrillationJob HarenbergPageof 13